Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.860
-0.020 (-0.52%)
At close: Sep 16, 2026, 4:00 PM EDT
3.860
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:15 PM EDT

Myriad Genetics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Myriad Genetics stock has a consensus rating of "Hold" and an average price target of $3.37. The average 1-year stock price forecast is 12.69% lower than the current stock price, while the lowest is $2.00 (-48.19%) and the highest is $5.00 (+29.53%).

Price Target: $3.37 (-12.69%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.00$3.37$3.20$5.00
Change-48.19%-12.69%-17.10%+29.53%

Analyst Ratings

The average analyst rating for Myriad Genetics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy111111
Buy111110
Hold765456
Sell111112
Strong Sell111111
Total111098910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$6$3.6
HoldMaintains$6$3.6-6.74%Sep 9, 2026
Piper Sandler
Piper Sandler
Sell
Downgrades
$8.5$2
SellDowngrades$8.5$2-48.19%Sep 1, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Sell
Maintains
$2.5
SellMaintains$2.5-35.23%Aug 21, 2026
Stephens
Stephens
Hold
Reiterates
$3
HoldReiterates$3-22.28%Aug 18, 2026
Unknown Analyst
Guggenheim
No rating
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
777.82M
from 824.50M
Decreased by -5.66%
Revenue Next Year
821.16M
from 777.82M
Increased by 5.57%
EPS This Year
-0.75
from 0.06
EPS Next Year
-0.57
from -0.75
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
690.60M678.40M753.20M837.60M824.50M777.82M
Revenue Growth
23.99%-1.77%11.03%11.21%-1.56%-5.66%
Gross Profit
493.00M476.40M517.00M585.40M576.60M519.72M
Gross Margin
71.39%70.22%68.64%69.89%69.93%66.82%
Operating Income
-126.70M-123.70M-144.60M-88.00M-67.80M-75.96M
Net Income
-27.20M-112.00M-263.30M-127.30M-365.90M-143.33M
EPS
----0.06-0.75
Free Cash Flow
149.49M-115.71M-59.29M13.25M762.50K-16.50M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High784.0M
Avg777.8M
Low772.7M

Revenue Growth

Revenue Growth202620272028
High
-4.9%
Avg
-5.7%
Low
-6.3%

EPS Forecast

EPS202620272028
High-0.58
Avg-0.75
Low-0.89

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-